
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A leading cancer treatment center in Manchester seeks a Research and Innovation Coordinator (Band 6) to support oncology research and manage clinical trials. The role includes project management, compliance oversight, and line management of R&I Administrators. Applicants must have a postgraduate diploma or equivalent experience, strong communication and organizational skills, and a knowledge of GCP guidelines. This position comes with a permanent contract at 37.5 hours per week.
We have an exciting opportunity within the Research and Innovation (R&I) Office at The Christie NHS Foundation Trust for a Research and Innovation Coordinator (Band 6). This post is offered as a permanent contract at 37.5 h/week.
We are looking for an enthusiastic and motivated individual to support oncology research undertaken within The Christie Hospital NHS Foundation Trust. The prime purpose of the role is to support the performance of the R&I Office in setting up and managing hosted clinical trials against national NIHR high level objectives and regional and local performance metrics whilst ensuring compliance with regulatory and research governance requirements.
The role also involves line management responsibilities for the R&I Administrators.
Applicants should be qualified to at least postgraduate diploma level, or have an equivalent level of experience and, as a minimum, must meet the essential criteria listed in the person specification of the job description.
The Christie is one of Europe’s leading cancer centres, treating over 60,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country. We provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. We are also an international leader in research, with world first breakthroughs for over 100 years. We run one of the largest early clinical trial units in Europe with over 300 trials every year.
This advert closes on Thursday 11 Dec 2025.